Clinical Impact of Primary Sclerosing Cholangitis on Outcomes of Inflammatory Bowel Disease Hospitalization: A Propensity Score Matching Analysis of the Nationwide Inpatient Sample
Journal of Digestive Diseases · 2025
DOI: 10.1111/1751-2980.13339 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Digestive Diseases, 2025. Verfasst von Xing Yu und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastroenterology, First Affiliated Hospital, Fujian Medical University, Fuzhou, Fujian Province, China. Hauptthemen laut MEDLINE: Cholangitis, Sclerosing, Inflammatory Bowel Diseases, Hospitalization. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 25 Literaturangaben. Gefördert von: The 2021 Joint Funds for the Innovation of Science and Technology, Fujian Province, Natural Science Foundation of Fujian Province.
Abstract (Originalsprache)
Objective
We aimed to evaluate the effect of primary sclerosing cholangitis (PSC) on hospitalization outcomes of inflammatory bowel disease (IBD) patients.
Methods
This retrospective study used data from the Nationwide Inpatient Sample (NIS) database from January 1, 2019, to December 31, 2020, including adults (≥ 18 years) admitted and diagnosed with IBD. Key outcomes included length of hospital stay (LOS), in‐hospital mortality, hospitalization cost, and complications. The propensity score matching (PSM) analysis was used to balance characteristics between IBD patients with and without PSC, followed by logistic regression for analysis.
Results
After PSM analysis, 4950 patients (PSC: 990; non‐PSC: 3960) were analyzed. IBD patients with PSC showed higher odds of any complication (odds ratio [OR] 2.08, 95% confidence interval [CI] 1.80–2.39), including acute kidney injury (OR 1.31, 95% CI 1.10–1.55), septic shock (OR 1.84, 95% CI 1.33–2.54), liver cirrhosis (OR 18.19, 95% CI 14.23–23.25), and liver failure (OR 8.33, 95% CI 5.93–11.70) (all p < 0.05). These associations were consistently observed across subgroups with stronger associations in the Crohn's disease subgroup.
Conclusions
PSC significantly increases the risk of short‐term complications in hospitalized IBD patients and the likelihood of chronic liver disease‐related complications. These findings highlight the need for targeted management strategies for IBD patients with co‐existing PSC.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Gastroenterology, First Affiliated Hospital, Fujian Medical University, Fuzhou, Fujian Province, China.
- Fujian Clinical Research Center for Liver and Intestinal Diseases, Fuzhou, Fujian Province, China.
- Department of Gastroenterology, National Regional Medical Center, Binhai Campus of the First Affiliated Hospital, Fujian Medical University, Fuzhou, Fujian Province, China.
- The First Clinical Medical College, Fujian Medical University, Fuzhou, Fujian Province, China.
ORCID-Profile: Cheng Dang Wang, Wei Wei Zheng
Förderung
- The 2021 Joint Funds for the Innovation of Science and Technology, Fujian Province
- Natural Science Foundation of Fujian Province
Zitieren
APA
Yu, X., Guo, J., Xue, M. L., Wang, C. D., & Zheng, W. W. (2025). Clinical Impact of Primary Sclerosing Cholangitis on Outcomes of Inflammatory Bowel Disease Hospitalization: A Propensity Score Matching Analysis of the Nationwide Inpatient Sample. Journal of Digestive Diseases. https://doi.org/10.1111/1751-2980.13339
Vancouver
Yu X, Guo J, Xue ML, Wang CD, Zheng WW. Clinical Impact of Primary Sclerosing Cholangitis on Outcomes of Inflammatory Bowel Disease Hospitalization: A Propensity Score Matching Analysis of the Nationwide Inpatient Sample. Journal of Digestive Diseases. 2025. doi:10.1111/1751-2980.13339
BibTeX
@article{Yu2025,
author = {Yu, Xing and Guo, Juan and Xue, Meng Li and Wang, Cheng Dang and Zheng, Wei Wei},
title = {Clinical Impact of Primary Sclerosing Cholangitis on Outcomes of Inflammatory Bowel Disease Hospitalization: A Propensity Score Matching Analysis of the Nationwide Inpatient Sample},
journal = {Journal of Digestive Diseases},
year = {2025},
doi = {10.1111/1751-2980.13339}
}
EUVIMED